Medical Innovation

Which Side Are You Really On, Jane Chin?!

I received what is probably the most passionate email from a reader of this blog that I’ve ever gotten since creating NakedMedicine.com in 2006. The email concludes with this: I can’t figure out what your agenda is Ms Chin. Are siding with the poor hard working physicians who are fighting a losing battle with their [...]

Read the full article →

We Already Have Been Personalizing Medicine

By Jane Chin, Ph.D. Let’s take the trend of “personalized medicine” to start. Yes, gene-based and protein-based medicines sound alluring. We talk about targeted therapies like they’re silver bullets against deadly diseases, when we still don’t know of the long term effects of many small molecule and biologics as medicines. All that talk about personalized [...]

Read the full article →

FDA Starts Podcasting

It’s about time – the U.S. Food and Drug Administration is offering a series of podcasts on timely drug safety topics. What’s nice about the FDA’s podcasts is that you may also read the transcript of the broadcast. As of this writing, there are 6 podcasts available, including a welcome podcast by Dr. Andy von [...]

Read the full article →

Neurodevices Target Depression

By Zack Lynch From this month’s Neurotech Insights investment newsletter focused on the depression market: While drugs to treat depression have proven effective for millions of individuals there exist a significant number of patients who do not respond to antidepressants. Treatment resistant depression, or refractory depression, is a condition that affects an estimated 4 million [...]

Read the full article →

Affordable Healthcare Dilemma

By Faiz Kermani Healthcare can be an emotionally charged subject. Therefore, it comes as little surprise that most governments around the world struggle to implement a healthcare policy that is acceptable to all. A growing component of healthcare expenditure is spending on pharmaceuticals, and this feature of medical care has received considerable attention. Complex issues [...]

Read the full article →